Literature DB >> 18474920

Nutritional management of patients undergoing surgery following diagnosis with encapsulating peritoneal sclerosis.

Declan de Freitas1, Antoinette Jordaan, Rosalind Williams, Jane Alderdice, Janet Curwell, Helen Hurst, Alastair Hutchison, Paul E C Brenchley, Titus Augustine, Angela M Summers.   

Abstract

BACKGROUND: Encapsulating peritoneal sclerosis (EPS) is a rare but serious complication of peritoneal dialysis (PD). Gastrointestinal (GI) symptoms affect appetite and dietary intake. Adequate nutrition is especially important if surgical interventions are required. AIM: To investigate the nutritional management of 23 EPS patients that underwent surgical intervention between 1999 and 2005 at Manchester Royal Infirmary, United Kingdom.
METHODS: EPS was recognized by GI symptoms and diagnostically confirmed by laparotomy, computed tomographic scanning, or biopsy.
RESULTS: Mean time on PD was 74 months (interquartile range 42-89 months). During the 12 months pre-diagnosis, 65% of the group showed significant weight loss (p = 0.0001), with 8 patients losing >10% of body weight; 74% of patients experienced significant albumin decrease (p = 0.001); and 56% of patients experienced GI symptoms during the 6 months pre-diagnosis. Nasogastric (NG) feeding was recommended for 8 patients but continued in only 1. 15 patients (mean albumin 27 g/L) commenced parenteral nutrition (PN); 9 patients recovered, with albumin increasing over the 6-month follow-up. Mean hospital time was 62 days for the group receiving neither NG nor PN, compared with 124.3 for the PN/NG group (p = 0.04). In patients that died of EPS, albumin continued to fall at 3 months post-diagnosis.
CONCLUSION: There is currently little guidance for nutritional management of EPS. From this study we recommend (1) a high level of clinical suspicion for EPS, especially if PD patients have weight loss; (2) PN may be better than NG feeding but further studies into dual enteral nutrition and PN are needed; (3) aggressive nutritional supplementation pre- and postoperatively; and (4) dietitians need to recognize the high risk of refeeding syndrome.

Entities:  

Mesh:

Year:  2008        PMID: 18474920

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  12 in total

Review 1.  Encapsulating peritoneal sclerosis in children.

Authors:  Constantinos J Stefanidis; Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2013-11-21       Impact factor: 3.714

Review 2.  Encapsulating peritoneal sclerosis.

Authors:  Christopher J Danford; Steven C Lin; Martin P Smith; Jacqueline L Wolf
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

Review 3.  Encapsulating peritoneal sclerosis: the state of affairs.

Authors:  Mario R Korte; Denise E Sampimon; Michiel G H Betjes; Raymond T Krediet
Journal:  Nat Rev Nephrol       Date:  2011-08-02       Impact factor: 28.314

4.  mTOR inhibitors for medical treatment of post-transplantation encapsulating peritoneal sclerosis: a favourable single center experience.

Authors:  Maria Messina; Claudia Ariaudo; Alberto Mella; Vincenzo Cantaluppi; Giuseppe P Segoloni; Luigi Biancone
Journal:  J Nephrol       Date:  2015-01-14       Impact factor: 3.902

5.  Anthropometrics Identify Wasting in Patients Undergoing Surgery for Encapsulating Peritoneal Sclerosis.

Authors:  Rosalind Campbell; Titus Augustine; Helen Hurst; Ravi Pararajasingam; David van Dellen; Sheilagh Armstrong; Carol Bartley; Linda Birtles; Angela Summers
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

Review 6.  Long-term peritoneal dialysis and encapsulating peritoneal sclerosis in children.

Authors:  Masataka Honda; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2010-01       Impact factor: 3.714

7.  Living with encapsulating peritoneal sclerosis (EPS): the patient's perspective.

Authors:  Helen Hurst; Angela Summers; Kinta Beaver; Ann-Louise Caress
Journal:  Perit Dial Int       Date:  2014-02-04       Impact factor: 1.756

Review 8.  Encapsulating peritoneal sclerosis-a rare but devastating peritoneal disease.

Authors:  Zia Moinuddin; Angela Summers; David Van Dellen; Titus Augustine; Sarah E Herrick
Journal:  Front Physiol       Date:  2015-01-05       Impact factor: 4.566

9.  Renal Association Clinical Practice Guideline on peritoneal dialysis in adults and children.

Authors:  Graham Woodrow; Stanley L Fan; Christopher Reid; Jeannette Denning; Andrew Neil Pyrah
Journal:  BMC Nephrol       Date:  2017-11-16       Impact factor: 2.388

10.  Nutrition changes in conservatively treated patients with encapsulating peritoneal sclerosis.

Authors:  Nevine El-Sherbini; Neill Duncan; Mary Hickson; Lina Johansson; Edwina A Brown
Journal:  Perit Dial Int       Date:  2013-07-01       Impact factor: 1.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.